©2008 The WJG Press and Baishideng.
World J Gastroenterol. Mar 14, 2008; 14(10): 1603-1611
Published online Mar 14, 2008. doi: 10.3748/wjg.14.1603
Published online Mar 14, 2008. doi: 10.3748/wjg.14.1603
Table 2 Median survival in different subgroups of patients with pancreatic cancer (breslow test)
| Patient subgroups | n | Median survival (mo) | P |
| Tumor location | |||
| Pancreatic head | 15 | 22 | 0.0204 |
| Pancreatic body or tail | 34 | 12 | |
| Tumor size | |||
| ≤ 4 cm | 24 | 13 | 0.7425 |
| > 4 cm | 25 | 14 | |
| Mode of cryosurgery | |||
| Inoperative | 13 | 11 | 0.1907 |
| Percutaneous | 36 | 14 | |
| Adjuvant chemotherapy | |||
| Yes | 20 | 11 | 0.0006 |
| No | 29 | 22 | |
| Hepatic metastases | |||
| Yes | 12 | 11 | 0.0088 |
| No | 37 | 19 |
- Citation: Xu KC, Niu LZ, Hu YZ, He WB, He YS, Li YF, Zuo JS. A pilot study on combination of cryosurgery and 125iodine seed implantation for treatment of locally advanced pancreatic cancer. World J Gastroenterol 2008; 14(10): 1603-1611
- URL: https://www.wjgnet.com/1007-9327/full/v14/i10/1603.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.1603